BOSTON and BERLIN, May 23, 2011 /PRNewswire/ — Boston
Healthcare announced today that it has acquired Alpha Care GmbH, a
consulting firm based in Germany that provides health economics and
policy solutions for pharmaceutical, medical device, payer and
provider organizations. Through this acquisition, Boston Healthcare
will expand its health economics, pricing and market access
consulting practice in Europe. The establishment of a new office in
Berlin, Germany, will allow Boston Healthcare to enhance the
delivery of its services to global pharmaceutical, medical device
and diagnostics companies.
(Logo:
http://photos.prnewswire.com/prnh/20110523/NE04879LOGO)
The Berlin office will be led by Prof. Bernd Brueggenjuergen,
MD, MPH, who will continue as Managing Director at Boston
Healthcare GmbH, and will support global clients in market access,
pricing, reimbursement and funding policies in Germany,
complementing Boston Healthcare’s global services. Prior to
co-founding Alpha Care with Prof. Stefan Willich of the University
Medicine Berlin Charite, Prof. Brueggenjuergen served as Head of
Health Economics and Disease Management at GlaxoWellcome in
Germany, and is currently Professor of Health Economics at the
Steinbeis University in Berlin. “Securing access to innovation in
health care is a key issue in all major markets and increasingly
requires a global exchange and expertise,” said Prof.
Brueggenjuergen.
“The addition of Prof. Brueggenjuergen, and his colleagues, to
the Boston Healthcare team will provide our clients with enhanced
in-market support in health economics and market access in Europe,”
said Joseph V. Ferrara, President of Boston Healthcare. “Germany is
one of the largest pharmaceutical and medical device markets in the
world, as well as a leader in health care technology innovation.
Our presence in Germany will enhance our ability to serve these
innovative companies.”
About Boston Healthcare:
Boston Healthcare
‘/>”/>
